Showing posts with label congenital anomalies. Show all posts
Showing posts with label congenital anomalies. Show all posts
Tuesday, February 4, 2014
Article-Major Congenital Anomaly Risk Down for Older Moms
(HealthDay News) — Advanced maternal age is associated with decreased risk for major fetal congenital anomalies, according to a study presented at the annual meeting of the Society for Maternal-Fetal Medicine, held from February 3–8 in New Orleans See More>>>
Saturday, November 3, 2012
Article Defining Congenital Anomalies
A congenital anomaly may be viewed as a physical, metabolic, or anatomic deviation from the normal pattern of development that is apparent at birth or detected during the first year of life... More>>
Initial Research Shows Possible link to Excessive Intake of Vitamin A to Congenital Anomalies
...a variety of gross congenital anomalies are produced which include: encephaly, eye malformations, cleft palate, shortening of the mandible and maxilla, spina bifida with meningocele and hydrocephalus... See More>>
Ionizing Radiation Linked To Congenital Anomalies
Ionizing radiation is known to cause harm in mammalian organisms... See More>>
A rare association of major congenital malformations : a case report
Congenital abnormalities may be structural, behavioral, functional or metabolic disorders that
are present at birth. In most developed countries, statistics indicate that major structural anomalies are
present in 2%-3% of live-borne infants. Congenital anomalies account for 21% of infant mortality. <<See More>>
Saturday, October 13, 2012
Water Disinfection By-Products and the Risk of Congenital Anomalies in Kaunas
Abstract
There is growing evidence from epidemiological studies that maternal exposure to increased drinking water chlorination by-products – THM may be associated with congenital anomalies. The aim of this study was to evaluate the impact of maternal exposure during pregnancy to individual THM internal dose effect on the risk of congenital anomalies.
We conducted a population-based prospective study of 3074 Kaunas residents births in 2007–2009 using THM exposure estimated as internal dose. We used multivariate logistic regression analysis and compared the risk of any congenital anomalies in four exposure categories of THM internal dose quartiles. In addition, we conducted a linear regression models analysis with adjustment for maternal physiological, lifestyle and sociodemographic characteristics.
Effect estimates based on total THMs and chloroform quartiles, tended to increase congenital anomalies risk but there were no statistically significant effect. However, we found dose–response relationships for the bromodichloromethane (BDCM) internal dose and risk for any congenital anomalies. The adjusted odds ratio for fourth quartile vs. first quartile was 1.5, 95% CI 1.00–2.55. The OR per every 0.01 μg/d increase in BDCM internal dose was 1.03, 95% CI 1.00–1.07. Effect estimates associated with dibromochloromethane (DBCM) exposure levels also revealed statistically significant association with the congenital anomalies risk (OR 1.23, 95% CI 1.02-1.48).
The present study suggests that prenatal exposure to total THM have tendency to increase the risk of any congenital anomalies, while exposure to BDCM and DBCM statistically significantly increases the risk of any congenital anomaly.
We conducted a population-based prospective study of 3074 Kaunas residents births in 2007–2009 using THM exposure estimated as internal dose. We used multivariate logistic regression analysis and compared the risk of any congenital anomalies in four exposure categories of THM internal dose quartiles. In addition, we conducted a linear regression models analysis with adjustment for maternal physiological, lifestyle and sociodemographic characteristics.
Effect estimates based on total THMs and chloroform quartiles, tended to increase congenital anomalies risk but there were no statistically significant effect. However, we found dose–response relationships for the bromodichloromethane (BDCM) internal dose and risk for any congenital anomalies. The adjusted odds ratio for fourth quartile vs. first quartile was 1.5, 95% CI 1.00–2.55. The OR per every 0.01 μg/d increase in BDCM internal dose was 1.03, 95% CI 1.00–1.07. Effect estimates associated with dibromochloromethane (DBCM) exposure levels also revealed statistically significant association with the congenital anomalies risk (OR 1.23, 95% CI 1.02-1.48).
The present study suggests that prenatal exposure to total THM have tendency to increase the risk of any congenital anomalies, while exposure to BDCM and DBCM statistically significantly increases the risk of any congenital anomaly.
Keywords
drinking water by-products; THM; internal dose; congenital anomalies
Print ISSN: 1392-1649
Online ISSN: 2029-2139
Subscribe to:
Posts (Atom)